Zoetis Inc. (NYSE:ZTS) Announces Quarterly Dividend of $0.50

Key Points

• Zoetis Inc. declared a quarterly dividend of $0.50 per share, with a 1.4% yield, to be paid on December 2nd to shareholders of record as of October 31st.
• The company reported earnings per share of $1.76 for the last quarter, exceeding expectations, and forecasting $6.30 - $6.40 EPS for FY 2025.
• Zoetis maintains a payout ratio of 29.2%, indicating a well-supported dividend by its earnings.

Zoetis Inc. (NYSE:ZTS - Get Free Report) announced a quarterly dividend on Thursday, October 9th. Shareholders of record on Friday, October 31st will be paid a dividend of 0.50 per share on Tuesday, December 2nd. This represents a c) dividend on an annualized basis and a yield of 1.4%. The ex-dividend date is Friday, October 31st.

Zoetis has a payout ratio of 29.2% indicating that its dividend is sufficiently covered by earnings. Equities research analysts expect Zoetis to earn $6.75 per share next year, which means the company should continue to be able to cover its $2.00 annual dividend with an expected future payout ratio of 29.6%.

Zoetis Stock Performance

Shares of NYSE:ZTS opened at $143.32 on Friday. The business's fifty day moving average price is $149.36 and its two-hundred day moving average price is $154.60. Zoetis has a fifty-two week low of $139.34 and a fifty-two week high of $196.55. The stock has a market capitalization of $63.52 billion, a price-to-earnings ratio of 24.67, a price-to-earnings-growth ratio of 2.30 and a beta of 0.90. The company has a debt-to-equity ratio of 1.05, a current ratio of 1.76 and a quick ratio of 1.04.

Zoetis (NYSE:ZTS - Get Free Report) last announced its quarterly earnings results on Tuesday, August 5th. The company reported $1.76 earnings per share for the quarter, beating analysts' consensus estimates of $1.62 by $0.14. Zoetis had a return on equity of 56.90% and a net margin of 27.83%.The firm had revenue of $2.46 billion for the quarter, compared to analysts' expectations of $2.41 billion. During the same period in the prior year, the business posted $1.56 earnings per share. The business's revenue was up 4.2% compared to the same quarter last year. Zoetis has set its FY 2025 guidance at 6.300-6.400 EPS. As a group, analysts predict that Zoetis will post 6.07 EPS for the current fiscal year.

Institutional Investors Weigh In On Zoetis

Several large investors have recently modified their holdings of the business. Lindbrook Capital LLC increased its holdings in shares of Zoetis by 1.8% in the first quarter. Lindbrook Capital LLC now owns 3,715 shares of the company's stock worth $612,000 after acquiring an additional 65 shares in the last quarter. Scott & Selber Inc. increased its holdings in shares of Zoetis by 0.6% in the second quarter. Scott & Selber Inc. now owns 11,652 shares of the company's stock worth $1,817,000 after acquiring an additional 67 shares in the last quarter. North Star Asset Management Inc. increased its holdings in shares of Zoetis by 4.9% in the second quarter. North Star Asset Management Inc. now owns 1,441 shares of the company's stock worth $225,000 after acquiring an additional 67 shares in the last quarter. Secure Asset Management LLC grew its holdings in shares of Zoetis by 2.9% during the second quarter. Secure Asset Management LLC now owns 2,448 shares of the company's stock worth $382,000 after buying an additional 68 shares in the last quarter. Finally, Quotient Wealth Partners LLC grew its holdings in shares of Zoetis by 2.3% during the first quarter. Quotient Wealth Partners LLC now owns 3,167 shares of the company's stock worth $521,000 after buying an additional 72 shares in the last quarter. 92.80% of the stock is currently owned by institutional investors.

Zoetis Company Profile

Zoetis Inc engages in the discovery, development, manufacture, and commercialization of animal health medicines, vaccines, and diagnostic products and services in the United States and internationally. The company commercializes products primarily across species, including livestock, such as cattle, swine, poultry, fish, and sheep and others; and companion animals comprising dogs, cats, and horses.

This instant news alert was generated by narrative science technology and financial data from MarketBeat in order to provide readers with the fastest and most accurate reporting. This story was reviewed by MarketBeat's editorial team prior to publication. Please send any questions or comments about this story to contact@marketbeat.com.